The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Blockade of the renin???angiotensin system decreases adipocyte size with improvement in insulin sensitivity
Abstract
Developing diabetes mellitus when being treated for hypertension is associated with a three-fold increase in the long-term risk of suffering a cardiovascular event [1]. Several randomized studies investigating a variety of antihypertensive agents have demonstrated an increased incidence of new-onset diabetes in patients treated with β-blockers compared to those treated with angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) [2,3]. Similarly, studies have shown that ACEIs [4,5] and ARBs [6] reduce the risk of developing diabetes. How blockade of the renin–angiotensin system (RAS) reduces new onset diabetes is not well understood. In this issue of the journal, Furuhashi et al. [7] provide evidence to suggest that ACEIs and ARBs have beneficial effects on adipose tissue function that are associated with an improvement in insulin sensitivity in a rat model. It is now clear that adipose tissue does not simply act as a store for energy, but that it has a role as an endocrine organ and secretes many systemically acting peptides, including adiponectin and tumour necrosis factor (TNF)-α. Adiponectin is expressed in differentiated adipocytes and is found in high concentrations in the bloodstream of healthy individuals. Adiponectin acts systemically by enhancing endothelial-dependent and independent vasodilatation, stimulating glucose utilization and oxidation of fatty acids in muscle, and increasing insulin sensitivity in the liver. Obese and insulin-resistant subjects have reduced levels of adiponectin [8] and administration of adiponectin improves insulin sensitivity in animal models of insulin resistance [9]. TNF-α expression is increased in obese human and rodent adipose tissue and correlates with insulin resistance. Reducing TNF-α with soluble receptors results in an improvement in insulin sensitivity in obese rodents [10]. Adiponectin appears to be secreted in higher levels by smaller adipocytes and TNF-α is secreted in higher levels by larger adipocytes. A recent study of the effects of liposuction on insulin resistance showed that simply removing adipose tissue does not improve insulin sensitivity [11]. It would appear that it is the morphology and function of adipose tissue that affects insulin sensitivity. By affecting adipocyte morphology and function, the RAS may influence insulin sensitivity. Janke et al. [12] demonstrated that the differentiation of preadipocytes is inhibited by angiotensin II. Furthermore, they showed that coculture with mature human adipocytes similarly results in inhibition of differentiation. When either an angiotensin II type 1 receptor blocker or an ACE inhibitor was added to the culture medium, the effects of angiotensin II and the mature adipocytes were abolished. The authors further suggest that a local RAS in adipose tissue plays a role in regulating adipogenesis in human adipose tissue [12]. Sharma et al. [13] hypothesized that large adipocytes produce increased amounts of angiotensin II, which then inhibits the differentiation of preadipocytes. This causes a failure of adequate expansion of adipose tissue and the resulting deposition of lipids in other tissues. They further suggest that blockade of the RAS should result in a reversal of this ectopic lipid deposition and an improvement in insulin sensitivity [13]. Furuhashi et al. [7] investigated this hypothesis using a rat model of insulin resistance. They induced hypertension and insulin resistance in Sprague–Dawley rats by feeding them a diet high in fructose. It was demonstrated that those rats with insulin resistance had adipocyte hypertrophy and increased levels of triglyceride deposition in skeletal muscle compared to rats fed a normal diet and with normal insulin sensitivity. The authors further demonstrate that either an ACEI or ARB attenuates the adverse effects of a high fructose diet [7]. Although it has previously been suggested that increased levels of bradykinin are responsible for the effects of ACEI on insulin sensitivity [14], in this study, the ACEI and ARB were of similar efficacy in improving insulin sensitivity, suggesting that it is the reduction in angiotensin II receptor activation that is responsible for any improvement rather than a kinin effect. It is unfortunate that adiponectin was not measured, although previous research has shown that RAS blockade results in an increased concentration of adiponectin. Triglyceride levels in muscle were reduced in the drug-treated rats, but not significantly. This may be due to the relatively short period of treatment (only 2 weeks of drug treatment) whereas extension of the treatment duration may have led to a significant result being seen. This study provides further evidence for mechanisms that link adipose tissue to the metabolic syndrome and goes some way towards elucidating the mechanisms by which RAS blockade reduces insulin resistance and the onset of new diabetes. However, some caution is required when translating
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Skeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179
Storlien, L. H., Jenkins, A. B., Chisholm, D. J., Pascoe, W. S., Khouri, S., & Kraegen, E. W. (1991) · Diabetes · doi:10.2337/diab.40.2.280 · Cited by 967
Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease
Klein, S., Fontana, L., Young, V. L., Coggan, A. R., Kilo, C., Patterson, B. W., & Mohammed, B. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033179 · Cited by 917
Ramipril and the Development of Diabetes
Yusuf, S. (2001) · JAMA · doi:10.1001/jama.286.15.1882 · Cited by 541
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
Verdecchia, P., Reboldi, G., Angeli, F., Borgioni, C., Gattobigio, R., Filippucci, L., Norgiolini, S., Bracco, C., & Porcellati, C. (2004) · Hypertension · doi:10.1161/01.hyp.0000125726.92964.ab · Cited by 510
Failure of adipocyte differentiation causes type II diabetes mellitus?
Danforth, E. (2000) · Nature Genetics · doi:10.1038/79111 · Cited by 487
Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System
Engeli, S., Negrel, R., & Sharma, A. M. (2000) · Hypertension · doi:10.1161/01.hyp.35.6.1270 · Cited by 475
Cited by
Chronic Inflammation in Obesity and the Metabolic Syndrome
Monteiro, R., & Azevedo, I. (2010) · Mediators of Inflammation · doi:10.1155/2010/289645 · Cited by 1,186
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
The renin‐angiotensin system: a link between obesity, inflammation and insulin resistance
Kalupahana, N. S., & Moustaid‐Moussa, N. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00942.x · Cited by 276
Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue
Saxton, S. N., Clark, B. J., Withers, S. B., Eringa, E. C., & Heagerty, A. M. (2019) · Physiological Reviews · doi:10.1152/physrev.00034.2018 · Cited by 272
PPARγ-Activating Angiotensin Type-1 Receptor Blockers Induce Adiponectin
Clasen, R., Schupp, M., Foryst-Ludwig, A., Sprang, C., Clemenz, M., Krikov, M., Thöne-Reineke, C., Unger, T., & Kintscher, U. (2005) · Hypertension · doi:10.1161/01.hyp.0000168046.19884.6a · Cited by 257
Metadata
- Authors
- Kingston, R.
- Venue
- Journal of Hypertension
- Published
- 2004-10
- Volume
- 22
- Issue
- 10
- Pages
- 1867-1868
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1990950873
- Cited by
- 166
- References
- 11
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blockade of the renin???angiotensin system decreases adipocyte size with improvement in insulin sensitivity. https://app.cochat.ai/papers/10.1097/00004872-200410000-00006
- The paper
- Kingston, R. (2004). Blockade of the renin???angiotensin system decreases adipocyte size with improvement in insulin sensitivity. Journal of Hypertension. https://doi.org/10.1097/00004872-200410000-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.